Get started Log in

FRMM — Forum Markets Share News

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMicro CapSucker Stock

Market Cap
$43.95m
Enterprise Value
$65.80m
Revenue
$6.55m

Brief: 180 Life Sciences Begins Consultations With UK And U.S. Regulatory Authorities On Pathway For A Therapy That Could Prevent Progression Of Early-Stage Dupuytren’S Disease
31/05/2022 14:29
Brief: 180 Life Sciences Corp Files Prospectus Related To Proposed Resale Of 4.8 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
17/05/2022 23:06
Brief: 180 Life Sciences And University Of Oxford Announce Publication Of Positive Phase 2B Dupuytren's Disease Study Results In Lancet Rheumatology
29/04/2022 23:37
Brief: 180 Life Sciences Says FDA Declined To Grant Meeting About Prelim Discussion For Dupuytren's Disease Treatment
28/03/2022 14:30
U.S. STOCKS ON THE MOVE-Exxon Mobil, Xometry, Gannett
01/02/2022 16:15
Brief: 180 Life Sciences Says Entered Into New Licensing Agreement With University Of Oxford
15/12/2021 13:20
Brief: 180 Life Sciences Provides Follow-Up Information On Oxford University And The Company’S Successful Dupuytren’S Phase 2B Clinical Trial Results
06/12/2021 14:41
180 Life Sciences jumps as hand deformity therapy meets study main goals
06/12/2021 14:00
Brief: 180 Life Sciences Expands Patent Portfolio
22/11/2021 17:04
Brief: 180 Life Sciences Says Entered Into Settlement And Mutual Release Agreement With Mintz
20/09/2021 21:48
Brief: Celltrion Healthcare Says Co And 180 Life Sciences Enter Into Memorandum Of Understanding
20/09/2021 13:17
Brief: 180 Life Sciences Files Prospectus Related To Proposed Resale Of 515,315 Shares Of Common Stock By Selling Stockholders
25/08/2021 14:30
Brief: 180 Life Sciences Corp Files For Resale Of 5.44 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
20/07/2021 21:34
Brief: 180 Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
20/07/2021 13:33
Brief: 180 Life Sciences Regains Nasdaq Compliance For Certain Listing Rules
12/07/2021 15:16
Brief: 180 Life Sciences Corp Says Nasdaq Provided Written Notice To It That It Has Determined That Co Complies With Its Rules
12/07/2021 13:49
Brief: 180 Life Sciences Expands Scientific Fibrosis Platform With Collagen Vi As A Driver And Disease Biomarker In Human Fibrosis Published In The Febs Journal
07/07/2021 13:13
Brief: 180 Life Sciences Joins Russell Microcap Index
28/06/2021 14:30
Brief: 180 Life Sciences Corp. Announces The Appointment Of Russell T. Ray And Teresa Deluca To Board Of Directors
28/05/2021 13:22
Brief: 180 Life Sciences Says Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report On Form 10-Q
21/05/2021 21:51